|
GB1555654A
(en)
|
1977-06-25 |
1979-11-14 |
Exxon Research Engineering Co |
Agricultural burner apparatus
|
|
NO154918C
(no)
|
1977-08-27 |
1987-01-14 |
Bayer Ag |
Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
|
|
DE2834122A1
(de)
|
1978-08-03 |
1980-02-14 |
Bayer Ag |
Verfahren zur herstellung von 6-amino-6-desoxy-l-sorbose
|
|
DE2839309A1
(de)
|
1978-09-09 |
1980-03-27 |
Bayer Ag |
3,4,5-trihydroxypiperidin-derivate
|
|
DE2853573A1
(de)
|
1978-12-12 |
1980-07-03 |
Bayer Ag |
Herstellung von n-substituierten derivaten des l-desoxynojirimycins
|
|
DE3038901A1
(de)
|
1980-10-15 |
1982-05-06 |
Bayer Ag, 5090 Leverkusen |
Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins
|
|
DE3611841A1
(de)
|
1986-04-09 |
1987-10-15 |
Bayer Ag |
Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten
|
|
US5103008A
(en)
|
1989-08-17 |
1992-04-07 |
Monsanto Company |
Compound, N-butyl-deoxynojirimycin-6-phosphate
|
|
US5043273A
(en)
|
1989-08-17 |
1991-08-27 |
Monsanto Company |
Phosphorylated glycosidase inhibitor prodrugs
|
|
US4994572A
(en)
|
1989-10-12 |
1991-02-19 |
Monsanto Company |
Synthesis of nojirimycin derivatives
|
|
US5030638A
(en)
|
1990-02-26 |
1991-07-09 |
G. D. Searle & Co. |
Method of antiviral enhancement
|
|
US5200523A
(en)
|
1990-10-10 |
1993-04-06 |
Monsanto Company |
Synthesis of nojirimycin derivatives
|
|
US5206251A
(en)
|
1992-04-01 |
1993-04-27 |
G. D. Searle & Co. |
2- and 3- amino and azido derivatives of 1,5-iminosugars
|
|
US5399567A
(en)
|
1993-05-13 |
1995-03-21 |
Monsanto Company |
Method of treating cholera
|
|
WO1995022975A1
(en)
|
1994-02-25 |
1995-08-31 |
G.D. Searle & Co. |
Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus
|
|
WO1999029321A1
(en)
*
|
1997-12-11 |
1999-06-17 |
The Chancellor, Masters And Scholars Of The University Of Oxford |
Inhibition of membrane-associated viral replication
|
|
US6689759B1
(en)
|
1998-02-12 |
2004-02-10 |
G. D. Searle & Co. |
Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
|
|
EP1714676A3
(en)
|
1998-02-12 |
2006-11-15 |
G.D. Searle LLC. |
Use of N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
|
|
US6809083B1
(en)
|
1998-02-12 |
2004-10-26 |
Richard A. Mueller |
Use of N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections
|
|
US6610703B1
(en)
|
1998-12-10 |
2003-08-26 |
G.D. Searle & Co. |
Method for treatment of glycolipid storage diseases
|
|
GB9828474D0
(en)
|
1998-12-24 |
1999-02-17 |
British Aerospace |
Surface topology inspection
|
|
ATE402701T1
(de)
|
1999-02-12 |
2008-08-15 |
United Therapeutics Corp |
N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino- - glucitol zur behandlung von hepatitis-virus- infektionen
|
|
GB0100889D0
(en)
|
2001-01-12 |
2001-02-21 |
Oxford Glycosciences Uk Ltd |
Compounds
|
|
JP2003505430A
(ja)
|
1999-07-26 |
2003-02-12 |
ジー・ディー・サール・アンド・カンパニー |
デオキシノジリマイシンの長鎖ｎ−アルキル誘導体およびグルコセレブロシダーゼ酵素の糖脂質異常蓄積疾患の治療用の薬剤の製造のための使用
|
|
US7256005B2
(en)
|
1999-08-10 |
2007-08-14 |
The Chancellor, Masters And Scholars Of The University Of Oxford |
Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
|
|
EP1556036A2
(en)
*
|
2002-09-23 |
2005-07-27 |
The Chancellor, Masters And Scholars Of The University Of Oxford |
Use of iminosugar derivatives to inhibit ion channel activity
|
|
PT2857036T
(pt)
|
2003-01-31 |
2017-03-13 |
Mount Sinai School Of Medicine Of N Y Univ |
Terapia combinada para o tratamento de distúrbios de deficiência proteica
|
|
US7446098B2
(en)
|
2003-02-18 |
2008-11-04 |
Mount Sinai School Of Medicine Of New York University |
Combination therapy for treating protein deficiencies
|
|
US20060211752A1
(en)
*
|
2004-03-16 |
2006-09-21 |
Kohn Leonard D |
Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
|
|
US20050256168A1
(en)
|
2004-04-28 |
2005-11-17 |
Block Timothy M |
Compositions for oral administration for the treatment of interferon-responsive disorders
|
|
US7524829B2
(en)
|
2004-11-01 |
2009-04-28 |
Avi Biopharma, Inc. |
Antisense antiviral compounds and methods for treating a filovirus infection
|
|
GB0501352D0
(en)
|
2005-01-21 |
2005-03-02 |
Slingsby Jason H |
Use of glycosylation modulators in combination with membrane fusion inhibitors for treatment of infections caused by viruses bearing glycosylated envelope
|
|
US7638488B2
(en)
|
2005-03-08 |
2009-12-29 |
Intermune, Inc. |
Use of alpha-glucosidase inhibitors to treat alphavirus infections
|
|
KR20080056688A
(ko)
|
2005-03-16 |
2008-06-23 |
유니버시티 오브 옥스퍼드 |
Ｈｉｖ－ｉ용 만노스 면역원
|
|
AU2006247065B8
(en)
|
2005-05-17 |
2012-07-12 |
Amicus Therapeutics, Inc. |
A method for the treatment of Pompe disease using 1-deoxynojirimycin derivatives
|
|
AU2006272586A1
(en)
|
2005-07-27 |
2007-02-01 |
University Of Florida Research Foundation, Inc. |
Use of heat shock to treat ocular disease
|
|
CA2616537A1
(en)
|
2005-07-27 |
2007-02-01 |
University Of Florida Research Foundation, Inc. |
Small compounds that correct protein misfolding and uses thereof
|
|
US20070244184A1
(en)
|
2006-01-09 |
2007-10-18 |
Simon Fraser University |
Glycosidase inhibitors and methods of synthesizing same
|
|
AU2007241622A1
(en)
|
2006-04-24 |
2007-11-01 |
Academisch Medisch Centrum |
Improved treatment of cystic fibrosis
|
|
US8975280B2
(en)
*
|
2006-05-24 |
2015-03-10 |
The Chancellor, Masters And Scholars Of The University Of Oxford |
Deoxynojirimycin and D-arabinitol analogs and methods of using
|
|
US20080138351A1
(en)
|
2006-08-02 |
2008-06-12 |
United Therapeutics Corporation |
Liposome treatment of viral infections
|
|
JP2010510171A
(ja)
|
2006-08-21 |
2010-04-02 |
ユナイテッド セラピューティクス コーポレーション |
ウイルス感染症の治療のための併用療法
|
|
WO2008068548A1
(en)
|
2006-12-08 |
2008-06-12 |
Institut Necker |
Use of inhibitors of the glycosylation process for the prevention and treatment of genetic diseases
|
|
US8097728B2
(en)
*
|
2007-04-30 |
2012-01-17 |
Philadelphia Health & Education Corporation |
Iminosugar compounds with antiflavirus activity
|
|
US20090252785A1
(en)
|
2008-03-26 |
2009-10-08 |
University Of Oxford |
Endoplasmic reticulum targeting liposomes
|
|
KR101787434B1
(ko)
|
2009-02-24 |
2017-11-15 |
유나이티드 세러퓨틱스 코오포레이션 |
이미노슈가 및 아레나바이러스성 감염을 치료하는 방법
|
|
CN102427804A
(zh)
|
2009-03-27 |
2012-04-25 |
牛津大学之校长及学者 |
降低胆固醇水平的脂质体
|
|
JP5634510B2
(ja)
|
2009-06-12 |
2014-12-03 |
ユナイテッド セラピューティクス コーポレイション |
イミノ糖ならびにブニヤウイルスおよびトガウイルス疾患を治療する方法
|
|
KR101497194B1
(ko)
|
2009-09-04 |
2015-02-27 |
유나이티드 세러퓨틱스 코오포레이션 |
오르토믹소바이러스 감염의 치료 방법
|
|
JP5752689B2
(ja)
|
2009-09-04 |
2015-07-22 |
ユナイテッド セラピューティクス コーポレイション |
フィロウイルス疾患を治療するイミノ糖および方法
|
|
KR101459530B1
(ko)
|
2009-09-04 |
2014-11-07 |
유나이티드 세러퓨틱스 코오포레이션 |
폭스바이러스 감염의 치료 방법
|